Dumont & Blake Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-16,422
| Closed | -$527K | – | 169 |
|
|
2017
Q1 | $527K | Buy |
16,422
+325
| +2% | +$10.4K | 0.24% | 120 |
|
|
2016
Q4 | $584K | Sell |
16,097
-4,712
| -23% | -$171K | 0.27% | 115 |
|
|
2016
Q3 | $957K | Sell |
20,809
-110
| -0.5% | -$5.06K | 0.47% | 77 |
|
|
2016
Q2 | $1.05M | Sell |
20,919
-675
| -3% | -$33.9K | 0.53% | 65 |
|
|
2016
Q1 | $1.16M | Sell |
21,594
-450
| -2% | -$24.1K | 0.6% | 54 |
|
|
2015
Q4 | $1.45M | Buy |
22,044
+225
| +1% | +$14.8K | 0.74% | 40 |
|
|
2015
Q3 | $1.23M | Sell |
21,819
-4,878
| -18% | -$275K | 0.67% | 52 |
|
|
2015
Q2 | $1.58M | Hold |
26,697
| – | – | 0.77% | 39 |
|
|
2015
Q1 | $1.66M | Buy |
26,697
+45
| +0.2% | +$2.8K | 0.81% | 41 |
|
|
2014
Q4 | $1.53M | Hold |
26,652
| – | – | 0.76% | 46 |
|
|
2014
Q3 | $1.43M | Sell |
26,652
-250
| -0.9% | -$13.4K | 0.74% | 46 |
|
|
2014
Q2 | $1.41M | Sell |
26,902
-250
| -0.9% | -$13.1K | 0.71% | 47 |
|
|
2014
Q1 | $1.44M | Sell |
27,152
-748
| -3% | -$39.5K | 0.75% | 46 |
|
|
2013
Q4 | $1.12M | Sell |
27,900
-2,285
| -8% | -$91.6K | 0.58% | 68 |
|
|
2013
Q3 | $1.14M | Buy |
30,185
+200
| +0.7% | +$7.55K | 0.54% | 73 |
|
|
2013
Q2 | $1.18M | Buy |
+29,985
| New | +$1.18M | 0.71% | 55 |
|